1D5A Stock Overview
PLx Pharma Winddown Corp. operates as a commercial-stage drug delivery platform technology company in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
PLx Pharma Winddown Corp. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.0005 |
| 52 Week High | US$0.97 |
| 52 Week Low | US$0.0005 |
| Beta | 3.41 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -99.94% |
| 3 Year Change | -99.98% |
| 5 Year Change | -99.98% |
| Change since IPO | -99.99% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1D5A | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | 0% | -5.8% | -0.6% |
| 1Y | -99.9% | -31.3% | 4.9% |
Rentabilidad frente al sector: 1D5A obtuvo unos resultados inferiores a los del sector German Pharmaceuticals , que el año pasado arrojó un rendimiento del -28.2%.
Rentabilidad vs. Mercado: 1D5A obtuvo unos resultados inferiores a los del mercado German, que fue del 5.9% el año pasado.
Price Volatility
| 1D5A volatility | |
|---|---|
| 1D5A Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 6.9% |
| Market Average Movement | 4.7% |
| 10% most volatile stocks in DE Market | 9.6% |
| 10% least volatile stocks in DE Market | 2.4% |
Precio estable de las acciones: 1D5A no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: Datos insuficientes para determinar el cambio de volatilidad de 1D5A en el último año.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 18 | Pat Lonergan | https://plxpharma.com |
PLx Pharma Winddown Corp. Fundamentals Summary
| 1D5A fundamental statistics | |
|---|---|
| Market cap | €5.36k |
| Earnings (TTM) | -€25.36m |
| Revenue (TTM) | €4.18m |
0.0x
P/S Ratio0.0x
P/E RatioIs 1D5A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1D5A income statement (TTM) | |
|---|---|
| Revenue | US$4.54m |
| Cost of Revenue | US$4.34m |
| Gross Profit | US$203.00k |
| Other Expenses | US$27.78m |
| Earnings | -US$27.58m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.95 |
| Gross Margin | 4.47% |
| Net Profit Margin | -606.91% |
| Debt/Equity Ratio | 0% |
How did 1D5A perform over the long term?
See historical performance and comparison